BioAtla Inc
3.69
$
2.07 %
BioAtla Inc développe des anticorps conditionnelement actifs pour traiter les maladies graves, principalement le cancer, en utilisant leur plateforme technologique CAB (Conditionally Active Biologics).
Price history of BioAtla Inc
Price history of BioAtla Inc
Performance & Momentum
6 Months
91.67 %
1 Year
81.05 %
3 Years
97.93 %
5 Years
99.83 %
Similar stocks to BioAtla Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
